Working… Menu

ASCEND GO-2: Study of RVT-1401 for the Treatment of Patients With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03938545
Recruitment Status : Terminated (Sponsor decision based on premature unblinding of treatment allocations necessitated by program-wide review)
First Posted : May 6, 2019
Last Update Posted : June 3, 2021
Information provided by (Responsible Party):
Immunovant Sciences GmbH

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : February 2, 2021
Actual Study Completion Date : April 15, 2021